Exelixis | Spese Operative



Operating Expenses Cambiamento Data
Acadia Pharmaceuticals USD 232.19M 7.16M 2025-06
Agios Pharmaceuticals USD 139.51M 24.16M 2025-06
Amgen USD 6.52B 337M 2025-06
AstraZeneca USD 10.95B 1.04B 2025-06
Bayer EUR 10.73B 688M 2025-06
BioMarin Pharmaceutical USD 548.52M 27.27M 2025-06
Bristol-Myers Squibb USD 8.5B 265M 2025-06
Cytokinetics USD 178.28M 21.06M 2025-06
Eisai JPY 181.91B 7.35B 2025-06
Eli Lilly USD 8.54B 1.22B 2025-06
Exelixis USD 354.68M 13.9M 2025-07
Genmab DKK 565M 38M 2025-06
Glaxosmithkline GBP 7.42B 408M 2024-12
Incyte USD 904.7M 56.97M 2025-06
Ionis Pharmaceuticals USD 312.21M 34.21M 2025-06
MacroGenics USD 35.94M 20.58M 2024-12
Merck USD 9.44B 217M 2025-06
Moderna USD 1.04B 113M 2025-06
Neurocrine Biosciences USD 541.9M 7M 2025-06
Novartis USD 9.97B 1.02B 2025-06
Pfizer USD 11.62B 1.58B 2025-06
Sanofi EUR 6.77B 3.75B 2024-12
Takeda JPY 922.12B 206.21B 2025-06
Ultragenyx Pharmaceutical USD 274.38M 7.85M 2025-06
Xencor USD 76.78M 865K 2025-06


Exelixis Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.